Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 August 2010 - ........................................
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Compliant to GLP and testing guideline; adequate coherence between data, comments and conclusions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- for ethical reasons, as neither death nor clinical signs were noted among 3 rats at 300 mg/kg, no 2nd assay was done at this dose; however two assays were done at 2000 mg/kg as required by guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- idem above
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Details on test material:
- - Name of test material (as cited in study report): Distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products.
- Physical state: yellow liquid
- Purity: not indicated (complex composition)
- Lot/batch No.: LR_OXO_2010-07-12
- Date of analysis: 12 July 2010
- Expiration date of the lot/batch: July 2011
- Storage conditions of test material: at +4°C and under nitrogen gas.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Breeder: Janvier, Le Genest Saint-Isle, France
- Age at study initiation: approximately 8 weeks old
- Weight at study initiation: 208 +/- 4 g
- Fasting period before study: 18 hours
- Housing: polycarbonate cages with stainless steel lid
- Diet (e.g. ad libitum): free access to SSNIFF R/M-H pelleted diet
- Water (e.g. ad libitum): free access to bottles containing tap water (filtered with a 0.22 µm filter)
- Acclimation period: at least 5 days before the beginning of the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 50 +/- 20%
- Air changes (per hr): 12 cycles/hour
- Photoperiod (hrs dark / hrs light): 12 h / 12 h (7:00 - 19:00)
IN-LIFE DATES: From: 20 August 2010 To: 22 September 2010.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 and 200 mg/mL
- Justification for choice of vehicle: The test item was not soluble in purified water. A solution was obtained in corn oil at the concentration of 200 mg/mL.
DOSE VOLUME APPLIED: 10 mL/kg.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: As no information on the toxic potential of the test item was available, for animal welfare reasons,
the starting dose-level of 300 mg/kg was chosen. - Doses:
- 300 and 2000 mg/kg.
- No. of animals per sex per dose:
- 3 females per treatment step (300, 2000 and 2000 mg/kg).
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality: frequently during the hours following administration, then daily.
Clinical signs: at least once during the first 30 minutes, periodically during the first 24 hours for detection of possible treatment-related clinical signs and then daily.
Body weight: just before administration on day 1, then on days 8 and 15.
- Necropsy of survivors performed: yes (macroscopic)
Results and discussion
- Preliminary study:
- not applicable
Effect levels
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At the 300 and 2000 mg/kg dose-level, no deaths were noted.
- Clinical signs:
- other: At the 300 mg/kg dose-level (three females), no clinical signs were noted. At the 2000 mg/kg dose-level, hypoactivity or sedation and piloerection (in all animals), staggering gait (in 4 animals) and dyspnea (in 3 animals) were observed on day 1 only.
- Gross pathology:
- At necropsy, no apparent abnormalities were observed in any animal.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD0 of the test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products, was higher than 2000 mg/kg in rats.
- Executive summary:
The objective of this study was to evaluate the toxicity of the test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products, following a single oral administration in ratsaccording to OECD(No. 423, 17th December 2001) andCommission Regulation (EC) (No. 440/2008, B.1tris, 30 May 2008) guidelines.
The study was conducted in compliance with the principles of Good Laboratory Practice.
Methods
The test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products, was administered once by oral route (gavage) to groups of three fasted female Sprague-Dawley rats at dose-levels of 300 or 2000 mg/kg under a dosage-volume of 10 mL/kg. The test item was prepared in corn oil.
The study design was as follows:
Dose-level
(mg/kg)
Dosage-volume
(mL/kg)
Female
300
10
3
2000
10
3
2000
10
3
Each animal was observed at least once a day for mortality and clinical signs for a period of up to 14 days following the single administration. Body weight was recorded on day 1 and then on days 8 and 15.
On completion of the observation period, the animals were sacrificed and then submitted for a macroscopic post-mortem examination. No organ samples were taken.
The interpretation of results was based on the classification criteria laid down in Council Directive 67/548/EEC (and subsequent adaptations).
Results
At the 300 mg/kg dose-level (three females), no deaths and no clinical signs were noted.
When compared to CIT historical control data the body weight gain of the animals was not affected by treatment with the test item.
At necropsy, no apparent abnormalities were observed in any animal.
At the 2000 mg/kg dose-level (three females then confirmation on three other females), no deaths occurred.
Hypoactivity or sedation and piloerection (in all animals), staggering gait (in 4 animals) and dyspnea (in 3 animals) were observed on day 1 only. A body weight loss (-3%) was noted between day 8 and day 15 in one female.
When compared to CIT historical control data, a lower body weight gain was noted between day 1 and day 8 (vs. 41 ±in control data base) in one female and between day 8 and day 15 (vs.15 ±in control data base) in another female.
At necropsy, no apparent abnormalities were observed in any animal.
Conclusion
The oral LD0of the test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products, was higher than 2000 mg/kg in rats.
According to the classification criteria laid down in Council Directive 67/548/EEC (and subsequent adaptations), concerning the potential toxicity by oral route, the test item should not be classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Въпреки че ECHA предоставя много онлайн материали на Вашия език, част от страницата е налична само на английски език. Научете повече за многоезиковата практика на ECHA.
Добре дошли на уебсайта на ECHA. Уебсайтът не се поддържа напълно от Internet Explorer 7 (и по-стари версии). Обновете Internet Explorer с по-нова версия.
За да гарантираме, че се възползвате максимално от функциите на нашия уебсайт, сме въвели „бисквитки“.
FНаучете повече как използваме бисквитките.